Notable Labs News Today

Notable Labs (NASDAQ:NTBL – Free Report) had its target price decreased by Chardan Capital from $7.00 to $5.00 in a research report report published on Thursday morning, Benzinga reports. Chardan Capital currently has a buy rating on the stock. Separately, JMP Securities reiterated a market outperform rating and set a $9.00 target price on shares […]

JMP Securities reaffirmed their market outperform rating on shares of Notable Labs (NASDAQ:NTBL – Free Report) in a research note issued to investors on Monday morning, Benzinga reports. They currently have a $9.00 price objective on the stock. Separately, Chardan Capital lowered their price objective on Notable Labs from $9.00 to $7.00 and set a […]

Notable Labs (NASDAQ: ) just reported results for the fourth quarter of 2023. InvestorPlace Earnings is a project that leverages data from TradeSmith to…

Poster outlines the parameters for developing a flow-cytometry-based PPMP as a companion diagnostic to predict volasertib responders, based on a...

Notable Labs, Ltd. (NASDAQ:NTBL – Get Free Report) shares fell 3.1% on Monday . The stock traded as low as $1.23 and last traded at $1.26. 73,343 shares were traded during trading, a decline of 83% from the average session volume of 437,002 shares. The stock had previously closed at $1.30. Wall Street Analysts Forecast […]

Notable Labs (NASDAQ:NTBL – Get Free Report) is one of 422 public companies in the “Biotechnology” industry, but how does it contrast to its peers? We will compare Notable Labs to similar businesses based on the strength of its valuation, analyst recommendations, earnings, dividends, risk, profitability and institutional ownership. Analyst Ratings This is a summary […]

With its AI-powered technology, the company has developed a groundbreaking solution for identifying optimal drug treatments for individual dogs and cats with blood cancers.

Notable Labs (NASDAQ:NTBL – Get Free Report) is one of 985 public companies in the “Pharmaceutical preparations” industry, but how does it compare to its peers? We will compare Notable Labs to similar companies based on the strength of its institutional ownership, valuation, profitability, analyst recommendations, risk, dividends and earnings. Profitability This table compares Notable […]

/PRNewswire/ -- Notable Labs, Ltd. ("Notable") (Nasdaq: NTBL), a clinical stage therapeutic platform company developing predictive precision medicines for...

/PRNewswire/ -- Notable Labs, ("Notable") (Nasdaq: NTBL), a clinical stage therapeutic platform company developing predictive precision medicines for cancer...